PAVmed Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for PAVmed Inc. (PAVM) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income39.79-79.26-88.98-50.35-34.28
Depreciation & Amortization1.202.932.460.230.02
Stock Based Compensation7.0511.1419.5315.012.04
Change in Working Capital0.511.59-0.72-1.570.08
Change in Accounts Receivable0.04-0.040.18-0.200.00
Change in Accounts Payable-0.06-0.92-0.740.170.50
Change in Other Working Capital0.538.785.55-1.54-0.42
Other Operating Activities-9.288.785.55-4.0510.21
Net Cash from Operating Activities-33.55-52.04-70.99-40.59-21.91
Investing Activities
Capital Expenditures-0.06-0.24-1.54-1.47-0.06
Acquisitions-16.480.00-3.20-2.250.00
Sales/Maturities of Investments0.350.00-3.20-2.250.00
Other Investing Activities0.350.000.000.000.00
Net Cash from Investing Activities-16.180.76-4.74-3.72-0.06
Financing Activities
Debt Repayment-0.53-0.080.00-14.820.00
Common Stock Issued1.661.821.89126.2616.40
Common Stock Repurchased0.000.00-0.370.000.00
Other Financing Activities30.160.842.61-6.98-0.10
Net Cash from Financing Activities31.2831.1738.21104.3133.01
Summary
Net Change in Cash-18.45-20.11-37.5160.0011.04
Cash at Beginning of Period19.6439.7477.2617.260.00
Cash at End of Period1.1919.6439.7477.260.00
Free Cash Flow-33.61-52.28-72.53-42.06-21.97